|
⚲
|
| Keyboard |
| Hahn Brian M
✚
|
|
|---|---|
| CIK # | 0001589711 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001589711] | |
| 4 | [0001589711] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hahn Brian M | |
| Crescent Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-06-18 | Buy | 17,500 | $0.25 | 4,375 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2024-01-12 | Grant | 250,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2023-05-17 | Sell | 3,700 | $1.95 | 7,215 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2023-01-19 | Grant | 246,300 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2022-11-11 | Buy | 20,000 | $1.06 | 21,200 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2022-03-09 | Sell | 2,917 | $1.09 | 3,180 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2022-01-21 | Grant | 47,700 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2022-01-21 | Grant | 164,700 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2021-01-20 | Grant | 69,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2021-01-20 | Grant | 34,500 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2020-12-16 | Option exercise | 5,260 | $1.12 | 5,891 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2020-12-16 | Option exercise | 5,260 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2020-01-22 | Grant | 120,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2019-01-17 | Grant | 90,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2018-06-11 | Sell | 19,345 | $18.04 | 348,984 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2018-06-11 | Option exercise | 5,260 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2018-06-11 | Option exercise | 5,260 | $1.12 | 5,891 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2018-01-10 | Grant | 65,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2017-01-04 | Grant | 65,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2016-01-07 | Grant | 65,000 | $0.00 | |
| showing 20 of 24 most recent transactions | |||||